Immunique

Seongnam-si, South Korea Founded: 2021 • Age: 5 yrs
Developer of T-cell therapeutics to treat autoimmune diseases
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Immunique

Immunique is a company based in Seongnam-si (South Korea) founded in 2021. Immunique operates in a competitive market with competitors including Moderna, Cordlife, Horizon Therapeutics, Forge Biologics and argenx, among others.

  • Headquarter Seongnam-si, South Korea
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Immunique

Premium access

Detailed funding history for Immunique

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Immunique

Investments
Premium access

Investment portfolio details for Immunique

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Immunique

Premium access

Detailed financials for Immunique

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Immunique Comparisons

Immunique Primary company
Description
Developer of T-cell therapeutics to treat autoimmune disease...
Location
Seongnam-si, South Korea
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Immunique

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Immunique

Immunique operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Cordlife, Horizon Therapeutics, Forge Biologics and argenx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
mRNA-based therapeutics for diseases including cancer and infections are developed.
Locked Locked Locked
Cordlife is engaged in cord blood banking and diagnostics.
Locked Locked Locked
Developer of drugs for treating rare and autoimmune diseases
Locked Locked Locked
Gene therapies for rare diseases are developed to treat patients.
Locked Locked Locked
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
Locked Locked Locked
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
Premium access

Detailed competitors of Immunique

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Immunique

Premium access

Complete news archive for Immunique

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Immunique

Immunique was founded in 2021.

Immunique is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.

Lee Young Ho is the current CEO of Immunique.

Immunique was founded in 2021 and is based in Seongnam-si, South Korea. Focus is placed on the biotechnology sector, where T-cell therapeutics are developed to target autoimmune and immunodeficiency diseases. Regulatory T-cell treatments derived from cord blood immune cells form the core of operations. A range of incurable conditions is addressed through these cell-based solutions, with emphasis on clinical applicability in immunotherapy.

Immunique's top competitors include Moderna, argenx and Forge Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available